Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Sham-controlled Trial of Greater Occipital Nerve Block as Second Line Therapy for ED Patients With Acute Migraine

NCT02665273 is registered in ClinicalTrials.gov with Montefiore Medical Center as lead sponsor.

NCT NCT02665273
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02665273 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Sham-controlled Trial of Greater Occipital Nerve Block as Second Line Therapy for ED Patients With Acute Migraine
Lead sponsor
Montefiore Medical Center
Phase
Phase 3
Overall status
Completed
Start date
July 1, 2015
Completion date
January 31, 2018
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

migraine